News

Autorisation de l’ANSM à mettre sur le marché le réactif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations

Autorisation de mise sur le marché du dispositif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations Nous avons le plaisir d’annoncer la disponibilité immédiate* du dispositif médical UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations, permettant, par amplification gén…

Advanced Biological Laboratories Receives CE-IVD Registration for its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the First CE-IVD Marked Kit for SARS-CoV-2 genotyping clinical applications

SARS-CoV-2 Genotyping using Next Generation Sequencing (NGS) Now Suited to Small, Medium and High-throughput Clinical Settings. Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the first in-vitro diagnostics kit…

Read more

Spring SPECIAL OFFER

You are a new Client ? This offer is made for you !! Get your free sample kit among all our microbiology genotyping assays  (SANGER or Next Generation Sequencing)                                   Offer Available Un…

Read more

New Saliva Collection Kits Available to Ease Specimen Sampling

We are pleased to announce the immediate availability of Safe, Scalable, Simple, Soft and Stable saliva collection kits, CE-IVD marked, to help you with you saliva sampling projects.   For more information please contact us at the following email address: contact@ablsa.com

Read more

New Kit & Software for SARS-CoV-2 Whole Genome Sequencing

We are pleased to announce the immediate availability of the DeepChek® Assay Whole Genome SARS-CoV-2 Genotyping V1 and the DeepChek® CoV2 Software. Both combined, it offers an innovative end-to-end solution (for Research Use Only (RUO)) for SARS-CoV-2 whole genome sequencing and analysis: from SARS-…

#